atlanticatlantic

Vaccine Chaos Is Looming

/in

“Which vaccine or vaccines will prove the safest and the most effective and the most deployable? I think we don’t know yet. And that’s why having redundancy is good,” says Dan Barouch. Read Article

ABCABCNEWS

Vaccine Watch: Johnson and Johnson moves forward in vaccine trials

/in
ABC News’ Bob Woodruff reports on Johnson and Johnson’s move to phase 3 trials for its vaccine, which unlike other vaccines is intended to be administered only once. Watch interview

Another COVID-19 vaccine developed in Massachusetts entering Phase 3 trial

/in

After months of laboratory work and successful testing in rhesus macaque monkeys, researchers at Johnson & Johnson and Beth Israel Deaconess Medical center are now looking for 60,000 people to participate in Phase 3 trials. Read Article

GBH

COVID-19 Vaccine Developed In Partnership With Beth Israel Reaches Final Stage Of Testing

/in

A COVID-19 vaccine developed by Johnson & Johnson in partnership with Beth Israel Deaconess Medical Center has now entered its final stage of clinical trials, making it the fourth American company to reach that step. Watch interview

foxfoxbusiness

Johnson & Johnson’s COVID-19 candidate enters third trial phase

/in

The company will become the first to test the simpler regimen of its candidate which is being developed by Janssen Pharmaceutical Companies, Dr. Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, told FOX Business. Read Article

 

NYTNYT

Johnson & Johnson Begins Large Trial of Its One-Shot Vaccine

/in

Unlike some of its competitors, Johnson & Johnson’s vaccine does not need to be frozen and may require just one shot instead of two. Read Article

 

reuters

J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers

/in

“The benefits of a single-shot vaccine are potentially profound in terms of mass immunization campaigns and global pandemic control,” Dr. Dan Barouch.  Read Article

BGBoston Globe

Major study to start for COVID-19 vaccine developed by Johnson & Johnson, Beth Israel

/in

Up to 60,000 volunteers, including some in Boston, will take part in the trial following encouraging data from more limited testing. Read Article